Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome.
Cimolai
N
N
Department of Pathology, British Columbia's Children's Hospital, Vancouver, Canada.
Carter
J E
JE
Morrison
B J
BJ
Anderson
J D
JD
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000930:Antidiarrheals / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D003968:Diarrhea, Infantile / Q000188:drug therapy / Q000209:etiology; D004751:Enteritis / Q000188:drug therapy / Q000209:etiology*; D004926:Escherichia coli; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology*; D006801:Humans; D007223:Infant; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D000930:Antidiarrheals